DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Sharma P, Barlow WE, Godwin AK. et al.
Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313).
Ann Oncol 2018;
29: 654-660
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.